DK1177793T3 - Inhalerbar medicinsk aerosol til behandling eller forebyggelse af smerte - Google Patents

Inhalerbar medicinsk aerosol til behandling eller forebyggelse af smerte

Info

Publication number
DK1177793T3
DK1177793T3 DK01401947T DK01401947T DK1177793T3 DK 1177793 T3 DK1177793 T3 DK 1177793T3 DK 01401947 T DK01401947 T DK 01401947T DK 01401947 T DK01401947 T DK 01401947T DK 1177793 T3 DK1177793 T3 DK 1177793T3
Authority
DK
Denmark
Prior art keywords
treating
preventing pain
inhalable
pain
medical aerosol
Prior art date
Application number
DK01401947T
Other languages
English (en)
Inventor
Laurent Lecourt
Franck Lescure
Marc Lemaire
Original Assignee
Air Liquide Sante Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Sante Int filed Critical Air Liquide Sante Int
Application granted granted Critical
Publication of DK1177793T3 publication Critical patent/DK1177793T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01401947T 2000-08-03 2001-07-19 Inhalerbar medicinsk aerosol til behandling eller forebyggelse af smerte DK1177793T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0010065A FR2812545B1 (fr) 2000-08-03 2000-08-03 Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur

Publications (1)

Publication Number Publication Date
DK1177793T3 true DK1177793T3 (da) 2003-10-13

Family

ID=8853131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01401947T DK1177793T3 (da) 2000-08-03 2001-07-19 Inhalerbar medicinsk aerosol til behandling eller forebyggelse af smerte

Country Status (10)

Country Link
US (2) US20020033174A1 (da)
EP (2) EP1317926A1 (da)
JP (1) JP2002104963A (da)
AT (1) ATE247477T1 (da)
CA (1) CA2353364A1 (da)
DE (1) DE60100614T2 (da)
DK (1) DK1177793T3 (da)
ES (1) ES2202265T3 (da)
FR (1) FR2812545B1 (da)
PT (1) PT1177793E (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
WO2002094231A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of analgesics through an inhalation route
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
JP4549847B2 (ja) 2002-05-17 2010-09-22 イエール ユニバーシティ 肝炎の治療方法
EP1515731A1 (de) * 2002-06-12 2005-03-23 Air Liquide Deutschland GmbH Xenonhaltiges spasmolytikum
CN1668315A (zh) 2002-06-12 2005-09-14 梅瑟·格里斯海姆有限公司 使用含氙气体进行脑保护
JP2006508040A (ja) * 2002-07-05 2006-03-09 メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング キセノンを含有するアジュバント
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
FR2849779B1 (fr) 2003-01-15 2006-07-14 Air Liquide Sante Sa Utilisation de xenon ou de n2o dans le traitement des deteriorations cellulaires cerebrales post-ischemiques
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
WO2005037949A2 (en) 2003-10-07 2005-04-28 Chrysalis Technologies Incorporated Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine
RU2271815C2 (ru) * 2003-11-21 2006-03-20 Николай Евгеньевич Буров Способ аутоанальгезии ксенон-кислородной смесью
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
FR2929513B1 (fr) * 2008-04-02 2010-09-17 Air Liquide Traitement des migraines sans aura chez le femmes enceintes par inhalation de dioxygene gazeux.
US8191739B1 (en) 2008-05-30 2012-06-05 Amrep, Inc. Mixed gas method for filling aerosol containers and aerosol formulas for improved environmental profile by VOC/HFC reduction
TW201029689A (en) * 2008-11-03 2010-08-16 Schering Corp Elastomeric discharge member for nasal delivery device
US20100203156A1 (en) * 2009-02-09 2010-08-12 Meiler Steffen E Xenon as a treatment for hemoglobinopathy
FR2944969B1 (fr) * 2009-04-29 2011-08-26 Air Liquide Utilisation de n2o gazeux dans le traitement des douleurs chroniques
FR2956323B1 (fr) * 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
US9757529B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
AU2013388034B2 (en) 2013-04-30 2019-08-15 Aspeya US Inc. Dry powder formulations and methods of use
CN112656780A (zh) 2014-02-20 2021-04-16 奥迪托皮克股份有限公司 用于吸入的干粉制剂
TWI602585B (zh) 2014-03-25 2017-10-21 林信湧 一種用於治療阿茲海默症之吸入式醫藥組成物及其備製方法
TWI586383B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療關節炎之吸入式醫藥組成物及其備製方法
TWI601542B (zh) 2014-04-18 2017-10-11 林信湧 一種用於治療肺癌之吸入式醫藥組成物及其備製方法
TWI594772B (zh) 2014-04-18 2017-08-11 林信湧 一種用於治療高血壓之吸入式醫藥組成物及其備製方法
JP2016000081A (ja) * 2014-06-11 2016-01-07 日本光電工業株式会社 水素治療装置及び水素治療方法
JP6513924B2 (ja) * 2014-10-15 2019-05-15 鈴木　譲 携帯用混合ガスボンベ
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131648A (en) * 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
JPS6233115A (ja) * 1985-08-05 1987-02-13 Kao Corp 人体塗布用噴霧組成物
JPS6239531A (ja) * 1985-08-15 1987-02-20 Masahiko Shima 混合ガス
US4819834A (en) * 1986-09-09 1989-04-11 Minnesota Mining And Manufacturing Company Apparatus and methods for delivering a predetermined amount of a pressurized fluid
GB8917775D0 (en) * 1989-08-03 1989-09-20 Atomic Energy Authority Uk Aerosol inhaler
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5404871A (en) * 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
US5508045A (en) * 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5507277A (en) * 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US5724957A (en) * 1993-01-29 1998-03-10 Aradigm Corporation Intrapulmonary delivery of narcotics
US5694919A (en) * 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US6098620A (en) * 1993-01-29 2000-08-08 Aradigm Corporation Device for aerosolizing narcotics
CA2166970C (en) * 1993-07-15 2000-12-19 Oh-Seung Kwon Seals for use in an aerosol delivery device
US5803078A (en) * 1994-05-06 1998-09-08 Brauner; Mark E. Methods and apparatus for intrapulmonary therapy and drug administration
GB9420971D0 (en) * 1994-05-06 1994-12-07 Minnesota Mining & Mfg Aerosol valves
GB9706817D0 (en) * 1997-04-04 1997-05-21 Boc Group Plc Medical gas mixtures
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
NZ322588A (en) * 1995-11-13 1999-01-28 Pitmy Int Nv An administration medium containing nitrous oxide for use in conjunction with analgesics, anti-inflammatories and anti-pyretics to enhance their action
US5875776A (en) * 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
JP2001511160A (ja) * 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
JPH10279499A (ja) * 1997-04-04 1998-10-20 Takeda Chem Ind Ltd 子宮粘膜適用製剤
JPH1149665A (ja) * 1997-08-08 1999-02-23 Osaka Ship Building Co Ltd 消炎鎮痛用組成物およびそれを用いてなるエアゾール製品
US6016801A (en) * 1997-09-03 2000-01-25 Philips; Monir Wasef Nitrous oxide delivery system
US6125844A (en) * 1998-04-30 2000-10-03 Westwood Biomedical Portable oxygen based drug delivery system
US6260549B1 (en) * 1998-06-18 2001-07-17 Clavius Devices, Inc. Breath-activated metered-dose inhaler
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
GB9913677D0 (en) * 1999-06-11 1999-08-11 Imperial College Formulation
JP4932109B2 (ja) * 1999-07-12 2012-05-16 キャプニア インコーポレイテッド 頭痛、鼻炎及び他のありふれた病気を治す方法及び装置
WO2001005409A1 (de) * 1999-07-19 2001-01-25 Michael Georgieff Neues spinal- und epiduralanästhetikum
DE19938800A1 (de) * 1999-08-16 2001-02-22 Stefan Huebner Medizinisches Präperat zur Verabreichung flüchtiger Stoffe
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6406681B1 (en) * 2000-08-21 2002-06-18 Aeropharm Technology, Inc. Method of treating a systemic disease
US6514482B1 (en) * 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system

Also Published As

Publication number Publication date
DE60100614D1 (de) 2003-09-25
FR2812545A1 (fr) 2002-02-08
CA2353364A1 (fr) 2002-02-03
EP1317926A1 (fr) 2003-06-11
FR2812545B1 (fr) 2003-03-28
ES2202265T3 (es) 2004-04-01
ATE247477T1 (de) 2003-09-15
EP1177793A1 (fr) 2002-02-06
EP1177793A8 (fr) 2002-05-08
US20020033174A1 (en) 2002-03-21
JP2002104963A (ja) 2002-04-10
DE60100614T2 (de) 2004-06-24
PT1177793E (pt) 2003-11-28
US20050180926A1 (en) 2005-08-18
EP1177793B1 (fr) 2003-08-20

Similar Documents

Publication Publication Date Title
DK1177793T3 (da) Inhalerbar medicinsk aerosol til behandling eller forebyggelse af smerte
CY1110842T1 (el) Φαρμακευτικες συνθεσεις για τη συντονισμενη διανομη των μσαφ
ATE325633T1 (de) Vorrichtung zur gleichzeitigen verabreichung von gasen und medikamenten
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
AU4451501A (en) Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
IT1303671B1 (it) Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
JO2178B1 (en) Treatment of emphysema using rar selective retinoid antagonists
DK1206257T3 (da) Anvendelse af aminosyrer til fremstilling af lægemidler, der er beregnet til behandling af insulinresistens
RU2003105901A (ru) Противовоспалительное лекарственное средство
AU2003235743A8 (en) Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
MXPA03002242A (es) Utilizacion de una hormona de liberacion (rh) para la preparacion de un medicamento para la prevencion de la degradacion del cartilago articular.
BR0318201A (pt) regime de dosagem de fármaco antiinflamatório não-esteroidal
DE60121047D1 (de) Pharmazeutische zusammensetzung zur behandlung von phimose mit einem topischen corticosteroid
NO331092B1 (no) Sammensetning bestaende av celecoxib og ibuprofen.
WO2002069968A8 (en) New use
DE60012575D1 (de) Nsaid enthaltendes wasserfreies gel zur topischen anwendung in der mundhöhle
HUP0300717A3 (en) Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
NO20032799L (no) Nye terapeutiske anvendelser av tienylcykloheksylamin- derivater
Fregnan et al. Biological properties of a new non-steroidal anti-inflammatory drug: etoclofene
Cushman Editorial Note: Propoxyphene Revisited
RU99105224A (ru) Способ местного лечения свищевого дерматита
TH49369A (th) การรวมกันของบีตา-2-อะกอนิสท์และสเทอรอยด์
WO2003097021A3 (en) Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea